secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pharma-Bio Serv, Inc. (PBSV)
CIK:        0001304161
Form:       8-K
Filed at:   2022-03-17T23:59:59+00:00
Accession:  0001654954-22-003384
Event type: earnings
Sentiment:  neutral
Materiality: 0.50
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pharma-Bio Serv Q1 revenue rises to $5.0M; net income flat at $0.3M
-------------------------------------------------------------------

- Revenue of $5.0M, up ~$0.5M YoY; net income unchanged at ~$0.3M.
- US and Europe consulting revenue grew to 33% of total, up from 22% YoY.
- CEO cites geographic diversification as key to future growth and risk reduction.
- No revised guidance or other material operational changes reported.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1304161/000165495422003384/0001654954-22-003384-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1304161/000165495422003384/pbsv_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-22-003384

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer